Aous Manshad

DDS | Dentist



  
  575 S Alameda Blvd, Las Cruces
  New Mexico, 88005

  575-528-6470    575-556-2930 Maps & Directions
Aous Manshad is a Las Cruces, New Mexico based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 575 S Alameda Blvd, Las Cruces. Patients can reach him at 575-528-6470.
Aous Manshad is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Aous Manshad speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Aous Manshad
Specialization: Dentist
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:575 S Alameda Blvd, Las Cruces,
New Mexico, 88005
Phone:575-528-6470
Fax:575-556-2930
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 6901172816
Enrollment ID: I20171020001374
NPI Number: 1265890081
NPI Enumeration Date: 08 Feb, 2016
NPI Last Update On: 26 Jul, 2018

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 385 Calle De Alegra Ste A,
Las Cruces, New Mexico
Zip: 88005-3423
Phone Number: 575-526-1105
Fax Number: 575-524-4266
Patients can reach Aous Manshad at 575 S Alameda Blvd, Las Cruces, New Mexico or can call to book an appointment on 575-528-6470. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.

Comments/ Reviews: